Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Approximately two-thirds of patients with the lysosomal storage disease mucopolysaccharidosis II have progressive cognitive impairment. Intravenous (i.v.) enzyme replacement therapy does not affect cognitive impairment because recombinant iduronate-2-sulfatase (idursulfase) does not penetrate the blood-brain barrier at therapeutic concentrations. We examined the safety of idursulfase formulated for intrathecal administration (idursulfase-IT) via intrathecal drug delivery device (IDDD). A secondary endpoint was change in concentration of glycosaminoglycans in cerebrospinal fluid.

          Related collections

          Author and article information

          Journal
          Genet. Med.
          Genetics in medicine : official journal of the American College of Medical Genetics
          Springer Nature
          1530-0366
          1098-3600
          Jan 2016
          : 18
          : 1
          Affiliations
          [1 ] Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
          [2 ] Department of Clinical Inherited Metabolic Disorders, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK.
          [3 ] Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
          [4 ] Department of Neurosurgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
          [5 ] Department of Paediatric Neurosurgery, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK.
          [6 ] Shire, Lexington, Massachusetts, USA.
          Article
          gim201536
          10.1038/gim.2015.36
          25834948
          d39083bd-f700-4e71-b434-47ec9cdb17a8
          History

          Comments

          Comment on this article